Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Synopsys

Here's How Much $100 Invested In Synopsys 10 Years Ago Would Be Worth Today

Synopsys (NASDAQ:SNPS) has outperformed the market over the past 10 years by 15.1% on an annualized basis producing an average annual return of 25.9%. Currently, Synopsys has a market capitalization of $46.08 billion.

Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2022

Walmart And 3 Other Stocks Insiders Are Selling

Walmart And 3 Other Stocks Insiders Are Selling

US stock futures traded slightly higher this morning on Monday after recording sharp gains in the previous session. Investors, meanwhile, focused on some notable insider trades.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,900 Today

Synopsys (NASDAQ:SNPS) has outperformed the market over the past 5 years by 22.62% on an annualized basis producing an average annual return of 31.23%. Currently, Synopsys has a market capitalization of $44.42 billion.

2 Top Electronics Design Automation Stocks to Buy Now

Rising demand for electronic design automation (EDA) tools with rapid technological advancements has been driving the industry’s growth. Therefore, we think investing in fundamentally sound EDA stocks Synopsys, Inc. (SNPS) and Cadence Design Systems (CDNS) could be wise. .

Here's How Much You Would Have Made Owning Synopsys Stock In The Last 10 Years

Synopsys (NASDAQ:SNPS) has outperformed the market over the past 10 years by 15.2% on an annualized basis producing an average annual return of 27.35%. Currently, Synopsys has a market capitalization of $50.46 billion.

2 Stocks to Buy After Raising Their Full Year Outlooks

Investors' concerns over the Federal Reserve's interest rate increases to combat inflationary pressures, and looming recession fears, have heightened market volatility. However, a few companies look sufficiently well positioned to withstand the current market turbulence and they recently raised their full-year outlooks. Therefore, we think it could be wise to…

inkl

Read news from The Economist, FT, and more,
with one subscription

Synopsys: A High-Quality Growth Stock to Buy Now

Synopsys: A High-Quality Growth Stock to Buy Now

Thanks to strategic partnerships and acquisitions, technology company Synopsys (SNPS) has achieved considerable operating-margin expansion across its business sectors. And given the company’s strong fundamentals and potential for long-term profitable growth, we think its stock is a great bet now. Read on.

Synopsys Stock Gains After Q2 Results Tops Estimates, Raised FY22 Guidance

Synopsys Stock Gains After Q2 Results Tops Estimates, Raised FY22 Guidance

Synopsys, Inc. (NASDAQ: SNPS) reported secon

Recap: Synopsys Q2 Earnings

Recap: Synopsys Q2 Earnings

Synopsys (NASDAQ:SNPS) reported its Q2 earnings results on Wednesday, May 18, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Synopsys beat estimated earnings by 5.49%, reporting an EPS of $2.5 versus an estimate of $2.37.

Adobe vs. Synopsys: Which Growth Stock is a Better Buy?

Adobe vs. Synopsys: Which Growth Stock is a Better Buy?

Despite aggressive interest rate hikes expectations and other factors keeping the market volatile, the recovering labor market and substantial corporate profits have driven the performance of some quality growth stocks like Synopsys (SNPS) and Adobe (ADBE). But which of these two stocks is a better buy now? Read more to…

3 Beaten-Down Growth Stocks to Snatch Up in Q2 2022

3 Beaten-Down Growth Stocks to Snatch Up in Q2 2022

Despite no clarity on when the Russia-Ukraine war will end, surging inflation, and logistical hindrances, the U.S. economy looks sufficiently resilient to weather the crises. Given this backdrop, we think shares of beaten-down growth stocks IQVIA (IQV), West Pharmaceutical (WST), and Synopsys (SNPS) could soar in price in the coming…

This Foreboding Sign Looms Over Synopsys's Chart

This Foreboding Sign Looms Over Synopsys's Chart

If history is any guide, there may be trouble ahead for shares of Synopsys (NASDAQ:SNPS). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Synopsys: Q1 Earnings Insights

Synopsys: Q1 Earnings Insights

Synopsys (NASDAQ:SNPS) reported its Q1 earnings results on Wednesday, February 16, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Synopsys beat estimated earnings by 1.27%, reporting an EPS of $2.4 versus an estimate of $2.37.

Get all your
news in one place.

100's of premium titles.
One news app.

Synopsys Earnings Preview

Synopsys (NASDAQ:SNPS) is set to give its latest quarterly earnings report on Wednesday, 2022-02-16. Here's what investors need to know before the announcement. Analysts estimate that Synopsys will report an earnings per share (EPS) of $2.37.

1 … 3 4 5 6

Organisations

US Federal Reserve

Texas Instruments

B of A Securities

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

369,701 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play